Clinical trial
Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium
NCT03105869 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium
- Lead sponsor
- Poitiers University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 16, 2014
- Completion date
- December 31, 2016
- Enrollment
- 20 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer